Michael F. Giordano

Filings by Michael F. Giordano span 2 companies, the busiest being RAPT Therapeutics, Inc. and Epizyme, Inc. We count 8 filings; the first trade dates from 25 June 2020 and the latest from 3 March 2026.

Sales make up the whole of the open-market record (1 sale, €565k). Besides market trades, the filings include 3 share grants and 2 option exercises.

The record was last updated on 5 March 2026 with a transaction in RAPT Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.